Corcept Completes Enrollment in Phase 2 Dazals Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
Corcept 完成了针对肌萎缩性侧索硬化 (ALS) 患者的二期 Dazals 试验的入组
Corcept Completes Enrollment in Phase 2 Dazals Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
Corcept 完成了针对肌萎缩性侧索硬化 (ALS) 患者的二期 Dazals 试验的入组
使用浏览器的分享功能,分享给你的好友吧